Godsey & Gibb Inc’s Boston Scientific BSX Stock Holding History

Godsey & Gibb Inc’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30	Closed	-$2.93K	–	447
2025 Q3	$2.93K	Buy	+30	New	+$3.11K	﹤0.01%	325

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Godsey & Gibb Inc's BSX Position: Q4 2025 in Review

Godsey & Gibb Inc sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 30 shares — an estimated $2.93K sold.

Godsey & Gibb Inc first reported a position in BSX in Q3 2025 and held it in 1 quarter. The position peaked at $2.93K in Q3 2025. 1,785 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Godsey & Gibb Inc reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Godsey & Gibb Inc sold 30 Boston Scientific shares in Q4 2025, an estimated $2.93K.
Godsey & Gibb Inc first reported a position in Boston Scientific in Q3 2025 and held it in 1 quarter.
Godsey & Gibb Inc's Boston Scientific position peaked at $2.93K in Q3 2025.
1,785 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Godsey & Gibb Inc's 13F filing for Q4 2025, filed 27 Jan 2026.